Does TOFACITINIB Cause Neoplasm? 91 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 91 reports of Neoplasm have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.1% of all adverse event reports for TOFACITINIB.
91
Reports of Neoplasm with TOFACITINIB
0.1%
of all TOFACITINIB reports
2
Deaths
21
Hospitalizations
How Dangerous Is Neoplasm From TOFACITINIB?
Of the 91 reports, 2 (2.2%) resulted in death, 21 (23.1%) required hospitalization, and 1 (1.1%) were considered life-threatening.
Is Neoplasm Listed in the Official Label?
Yes, Neoplasm is listed as a known adverse reaction in the official FDA drug label for TOFACITINIB.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Neoplasm?
ADALIMUMAB (513)
OCTREOTIDE (366)
RITUXIMAB (323)
LENALIDOMIDE (242)
CYCLOPHOSPHAMIDE (221)
BEVACIZUMAB (207)
INFLIXIMAB (201)
ETANERCEPT (194)
RIBOCICLIB (194)
METHOTREXATE (165)
Which TOFACITINIB Alternatives Have Lower Neoplasm Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN